miR‑124‑3p inhibits the viability and motility of glioblastoma multiforme by targeting RhoG

The mortality rate of patients with glioma is increasing worldwide per annum. This is attributed to the poor disease prognosis, most notably for high‑grade gliomas (grade III and IV), which does not improve the overall patient survival. The dysregulation of microRNA (miRNA/miR)‑124‑3p is found in a...

Ausführliche Beschreibung